| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.092 | 0.06 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.087 | 0.07 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.085 | 0.09 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.079 | 0.09 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.079 | 0.09 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.076 | 0.09 |